Resolian, a renowned global leader in providing bioanalytical, DMPK, and CMC testing services to the pharmaceutical and biopharmaceutical industry, has proudly inaugurated its cutting-edge analytical laboratory spanning an impressive 440m² in Fordham, Cambridgeshire, UK.
This latest facility, the plans for which were unveiled earlier this year, presents a substantial 30% increase in laboratory space, effectively addressing the escalating demand for analytical and materials science work.
Ellen Stokvis, the Director of Analytical Sciences Operations, expressed her delight, stating, “We are thrilled to have expanded our laboratory in Fordham, augmenting its size by over 30% to cater to the growing demand. Our new state-of-the-art purpose-built facility reinforces our analytical and materials science capabilities, allowing a broader range of companies to benefit from our services.
“The redesigned laboratory space has been thoughtfully designed to foster enhanced collaboration, optimise workflow, and streamline traffic flow. Combined with our existing Sandwich site, this significant investment in our analytical and materials science division ensures that we are fully prepared to meet both the current and future demands of our valued customers.”
For further details on how Resolian continues to evolve, offering specialised support across the drug development continuum on a global scale, interested parties are encouraged to visit the company’s newly launched website.
